Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Pregnancy Complications » Obstetric Labor Complications » Postpartum Hemorrhage
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Pregnancy Complications » Puerperal Disorders » Postpartum Hemorrhage
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Hemorrhage » Uterine Hemorrhage » Postpartum Hemorrhage
Description
Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate (within first 24 hours after birth) or delayed (after 24 hours postpartum). MeSH
Hierarchy View
Approved Indicated Drugs (3)
Phase 4 Indicated Drugs (15)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (2)
Other Experimental Indicated Drugs (16)
Organization Involved with Phase 4 Indications (48)
Al- Elweyia Maternity Teaching Hospital
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Central California Faculty Medical Group
Organization Involved with Phase 3 Indications (49)
Aase and Ejnar Danielsens Foundation
Azienda U.S.L. 1 di Massa e Carrara
Blood Bank of the Danish capital region
Canadian Institutes of Health Research (CIHR)
Institut National de la Santé Et de la Recherche Médicale, France
Jawaharlal Nehru Medical College
KK Women's and Children's Hospital
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (59)
Bagcilar Research and Training Hospital
Bill and Melinda Gates Foundation
Canadian Anesthesiologists' Society
Dongguan Maternity & Child Health Hospital
Dr. D. Y. Patil Dental College & Hospital
Etlik Zubeyde Hanim Womens' Health and Teaching Hospital
Hospital Gineco Obstetrico Isidro Ayora
Icahn School of Medicine at Mount Sinai
Jiangmen Maternity & Child Health Care Hospital
Kanuni Sultan Suleyman Training and Research Hospital
Kurdistan Board for Medical Speciality
Mbale Regional Referral Hospital
MOH Etlik Zubeyde Hanim Women's Health Training and Research Hospital
Nanhai Maternity & Child Healthcare Hospital
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Child Health and Human Development (NICHD)
National Institute of Dental and Craniofacial Research (NIDCR)
National University of Malaysia
New York City Health and Hospitals Corporation
Secretariat of His Highness the Aga Khan, Aiglemont
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
